CMIC which established its CRO business in 1992, has supported such drug development-related activities as monitoring, data management, recruiting of test subjects and clinical test coordination as Japan's first CRO. Capitalizing on the long years of experience and know-how as a CRO, it engages mainly in PVC (Pharmaceutical Value Creator) activities including CMO and CSO, in support of the value chains of pharmaceutical companies. CMIC has a presence not only in Japan but in Asia (China, Korea, Singapore and Taiwan -China- ), Brazil and U.S.A, and engages in a wide range of activities.